Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vinochani Pillay

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Journal of Microbiological Methods|November 25, 2010
Optimisation of an in vitro antifungal protein assay for the screening of potential antifungal proteins against Leptosphaeria maculansVinochani Pillay, Gideon M Polya, German C Spangenberg
New Biotechnology|April 9, 2011
Antibodies in oncologyVinochani Pillay, Hui K Gan, Andrew M Scott
Trends in Biotechnology|November 7, 2006
The urokinase plasminogen activator receptor as a gene therapy target for cancerVinochani Pillay, Crispin R Dass, Peter F M Choong
Mutation Research|June 30, 2009
A novel and simple method of screening compounds for interaction with DNA: A validation studyAdel Garas, Elizabeth Webb, Vinochani Pillay, et al.
Molecular Cancer Therapeutics|April 14, 2007
Activation of clinically used anthracyclines by the formaldehyde-releasing prodrug pivaloyloxymethyl butyrateSuzanne M Cutts, Lonnie P Swift, Vinochani Pillay, et al.
Oncology Research|September 8, 2007
Formaldehyde-releasing prodrugs in combination with adriamycin can overcome cellular drug resistanceSuzanne M Cutts, Abraham Nudelman, Vinochani Pillay, et al.
Neoplasia (New York, N.Y.)|May 5, 2009
The plasticity of oncogene addiction: implications for targeted therapies directed to receptor tyrosine kinasesVinochani Pillay, Layal Allaf, Alexander L Wilding, et al.
ACS Chemical Biology|July 20, 2011
Humanized Lewis-Y specific antibody based delivery of STAT3 siRNAYuelong Ma, Claudia M Kowolik, Piotr M Swiderski, et al.
Blood|December 25, 2007
Activin-A: a novel dendritic cell-derived cytokine that potently attenuates CD40 ligand-specific cytokine and chemokine productionNeil C Robson, David J Phillips, Tristan McAlpine, et al.
Nature Communications|November 12, 2015
Targeted drug delivery using genetically engineered diatom biosilicaBahman Delalat, Vonda C Sheppard, Soraya Rasi Ghaemi, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Journal of Microbiological Methods|November 25, 2010
Optimisation of an in vitro antifungal protein assay for the screening of potential antifungal proteins against Leptosphaeria maculansVinochani Pillay, Gideon M Polya, German C Spangenberg
New Biotechnology|April 9, 2011
Antibodies in oncologyVinochani Pillay, Hui K Gan, Andrew M Scott
Trends in Biotechnology|November 7, 2006
The urokinase plasminogen activator receptor as a gene therapy target for cancerVinochani Pillay, Crispin R Dass, Peter F M Choong
Mutation Research|June 30, 2009
A novel and simple method of screening compounds for interaction with DNA: A validation studyAdel Garas, Elizabeth Webb, Vinochani Pillay, et al.
Molecular Cancer Therapeutics|April 14, 2007
Activation of clinically used anthracyclines by the formaldehyde-releasing prodrug pivaloyloxymethyl butyrateSuzanne M Cutts, Lonnie P Swift, Vinochani Pillay, et al.
Oncology Research|September 8, 2007
Formaldehyde-releasing prodrugs in combination with adriamycin can overcome cellular drug resistanceSuzanne M Cutts, Abraham Nudelman, Vinochani Pillay, et al.
Neoplasia (New York, N.Y.)|May 5, 2009
The plasticity of oncogene addiction: implications for targeted therapies directed to receptor tyrosine kinasesVinochani Pillay, Layal Allaf, Alexander L Wilding, et al.
ACS Chemical Biology|July 20, 2011
Humanized Lewis-Y specific antibody based delivery of STAT3 siRNAYuelong Ma, Claudia M Kowolik, Piotr M Swiderski, et al.
Blood|December 25, 2007
Activin-A: a novel dendritic cell-derived cytokine that potently attenuates CD40 ligand-specific cytokine and chemokine productionNeil C Robson, David J Phillips, Tristan McAlpine, et al.
Nature Communications|November 12, 2015
Targeted drug delivery using genetically engineered diatom biosilicaBahman Delalat, Vonda C Sheppard, Soraya Rasi Ghaemi, et al.
Pageof 2